Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2022 Filed Mar 7, 2022 22:46 UTC |
Chow Pok Yu AugustineDirector
|
GrantOption to Purchase Celsion Common Stock · Derivative | 7,500 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001437749-22-005410 · rdgdoc.xml · derivative · entry 1 Chow Pok Yu Augustine · CIK 0001392992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,742 Underlying: Celsion Corporation Common Stock · 7,500 shares Expires 2032-03-04 F1 · derivative.exercise_price: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant. F2 · derivative.exercise_date: The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 22:45 UTC |
Fritz Frederick J.Director
|
GrantOption to Purchase Celsion Common Stock · Derivative | 7,500 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001437749-22-005409 · rdgdoc.xml · derivative · entry 1 Fritz Frederick J. · CIK 0001525250 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,504 Underlying: Celsion Corporation Common Stock · 7,500 shares Expires 2032-03-04 F1 · derivative.exercise_price: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the date of grant; 1/3 on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 17:49 UTC |
Fritz Frederick J.Director
|
PurchaseCelsion Corporation Common Stock | 2,000 | $4.69 | $9,372.00 |
DisclosureSEC source: 0001437749-22-005117 · rdgdoc.xml · nonDerivative · entry 1 Fritz Frederick J. · CIK 0001525250 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,766 F1 · shares: The shares were purchased on the open market. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:42 UTC |
Kardaras Constantine JohnChief Accounting Officer
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 35,000 | $0.63 Strike: $0.63 | $22,050.00 |
DisclosureSEC source: 0001437749-21-028762 · rdgdoc.xml · derivative · entry 2 Kardaras Constantine John · CIK 0001899660 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Celsion Corporation Common Stock · 35,000 shares Expires 2031-12-14 F3 · derivative.exercise_price: Represents the per share fair value of the common stock based on the closing price of a share of Celsion Common Stock on the date of the award. F3 · price: Represents the per share fair value of the common stock based on the closing price of a share of Celsion Common Stock on the date of the award. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:42 UTC |
Kardaras Constantine JohnChief Accounting Officer
|
GrantCelsion Corporation Common Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-028762 · rdgdoc.xml · nonDerivative · entry 1 Kardaras Constantine John · CIK 0001899660 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · shares: Stock grant award which will vest on the first anniversary of hire date (December 6, 2022). Fair value of the stock award is $0.63 per share based on the closing price of Celsion Common Stock the award date. Read SEC document |
| October 07, 2021 Filed Oct 8, 2021 12:50 UTC |
Fritz Frederick J.Director
|
PurchaseCelsion Corporation Common Stock | 20,000 | $0.88 | $17,600.00 |
DisclosureSEC source: 0001437749-21-023474 · rdgdoc.xml · nonDerivative · entry 1 Fritz Frederick J. · CIK 0001525250 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,491 F1 · shares: The shares were purchased on the open market. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 20:20 UTC |
Pellizzari Christine ADirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 40,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001437749-21-014425 · rdgdoc.xml · derivative · entry 1 Pellizzari Christine A · CIK 0001127430 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Celsion Corporation Common Stock · 40,000 shares Expires 2031-06-08 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on January 1, 2022; 1/3 on January 1, 2023; and 1/3 on January 1, 2024. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 20:21 UTC |
Lindborg StacyDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 40,000 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001437749-21-014321 · rdgdoc.xml · derivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Celsion Corporation Common Stock · 40,000 shares Expires 2031-06-04 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on January 1, 2022; 1/3 on January 1, 2023; and 1/3 on January 1, 2024. Read SEC document |
| May 17, 2021 Filed May 20, 2021 18:10 UTC |
Braun Donald PDirector
|
PurchaseCelsion Corporation Common Stock | 5,000 | $1.07 | $5,350.00 |
DisclosureSEC source: 0001437749-21-012889 · rdgdoc.xml · nonDerivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,357 F1 · shares: The shares were purchased on the open market. Read SEC document |
| March 19, 2021 Filed Mar 22, 2021 20:55 UTC |
Tumminello Timothy JController
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 65,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001437749-21-006775 · rdgdoc.xml · derivative · entry 1 Tumminello Timothy J · CIK 0001480334 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,557 Underlying: Celsion Corporation Common Stock · 65,000 shares Expires 2031-03-19 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 immediately; 1/3 on the first year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant. Read SEC document |
| March 19, 2021 Filed Mar 22, 2021 20:54 UTC | GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 275,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001437749-21-006774 · rdgdoc.xml · derivative · entry 1 CHURCH JEFFREY WAYNE · CIK 0001240203 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 714,951 Underlying: Celsion Corporation Common Stock · 275,000 shares Expires 2031-03-19 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 immediately; 1/3 on the first year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant. Read SEC document |
|
| March 19, 2021 Filed Mar 22, 2021 20:53 UTC |
Tardugno Michael HDirector · Chairman, President and CEO
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 650,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001437749-21-006773 · rdgdoc.xml · derivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,996,071 Underlying: Celsion Corporation Common Stock · 650,000 shares Expires 2031-03-19 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 immediately, 1/3 on the first anniversary of the date of grant and 1/3 on the second year anniversary of the date of grant. Read SEC document |
| March 19, 2021 Filed Mar 22, 2021 20:48 UTC |
Voss AndreasDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 40,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001437749-21-006769 · rdgdoc.xml · derivative · entry 1 Voss Andreas · CIK 0001661447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,357 Underlying: Celsion Corporation Common Stock · 40,000 shares Expires 2031-03-19 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| March 19, 2021 Filed Mar 22, 2021 20:47 UTC |
Braun Donald PDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 40,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001437749-21-006767 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,357 Underlying: Celsion Corporation Common Stock · 40,000 shares Expires 2031-03-19 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| March 19, 2021 Filed Mar 22, 2021 20:44 UTC |
Fritz Frederick J.Director
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 40,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001437749-21-006766 · rdgdoc.xml · derivative · entry 1 Fritz Frederick J. · CIK 0001525250 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,118 Underlying: Celsion Corporation Common Stock · 40,000 shares Expires 2031-03-19 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| March 19, 2021 Filed Mar 22, 2021 20:43 UTC |
Hooper Robert WDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 40,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001437749-21-006765 · rdgdoc.xml · derivative · entry 1 Hooper Robert W · CIK 0001497872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,737 Underlying: Celsion Corporation Common Stock · 40,000 shares Expires 2031-03-19 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| March 19, 2021 Filed Mar 22, 2021 20:42 UTC |
Chow Pok Yu AugustineDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 40,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001437749-21-006764 · rdgdoc.xml · derivative · entry 1 Chow Pok Yu Augustine · CIK 0001392992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,689 Underlying: Celsion Corporation Common Stock · 40,000 shares Expires 2031-03-19 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:10 UTC |
Tumminello Timothy JController
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 80,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001437749-20-013256 · rdgdoc.xml · derivative · entry 3 Tumminello Timothy J · CIK 0001480334 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,557 Underlying: Celsion Corporation Common Stock · 80,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · derivative.underlying_shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:10 UTC |
Tumminello Timothy JController
|
Disposition to issuerOption to Purchase Celsion Corporation Common Stock · Derivative | 80,000 | $0.00 Strike: $2.22 | $0.00 |
DisclosureSEC source: 0001437749-20-013256 · rdgdoc.xml · derivative · entry 2 Tumminello Timothy J · CIK 0001480334 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,557 Underlying: Celsion Corporation Common Stock · 80,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · derivative.underlying_shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:10 UTC |
Tumminello Timothy JController
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 25,000 | $0.00 Strike: $3.66 | $0.00 |
DisclosureSEC source: 0001437749-20-013256 · rdgdoc.xml · derivative · entry 1 Tumminello Timothy J · CIK 0001480334 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,557 Underlying: Celsion Corporation Common Stock · 25,000 shares Expires 2030-06-15 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:09 UTC | GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 250,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001437749-20-013255 · rdgdoc.xml · derivative · entry 3 CHURCH JEFFREY WAYNE · CIK 0001240203 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 439,951 Underlying: Celsion Corporation Common Stock · 250,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
|
| June 15, 2020 Filed Jun 16, 2020 21:09 UTC | Disposition to issuerOption to Purchase Celsion Corporation Common Stock · Derivative | 250,000 | $0.00 Strike: $2.22 | $0.00 |
DisclosureSEC source: 0001437749-20-013255 · rdgdoc.xml · derivative · entry 2 CHURCH JEFFREY WAYNE · CIK 0001240203 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,951 Underlying: Celsion Corporation Common Stock · 250,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · derivative.underlying_shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
|
| June 15, 2020 Filed Jun 16, 2020 21:09 UTC | GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 55,000 | $0.00 Strike: $3.66 | $0.00 |
DisclosureSEC source: 0001437749-20-013255 · rdgdoc.xml · derivative · entry 1 CHURCH JEFFREY WAYNE · CIK 0001240203 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 439,951 Underlying: Celsion Corporation Common Stock · 55,000 shares Expires 2030-06-15 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
|
| June 15, 2020 Filed Jun 16, 2020 21:09 UTC |
Tardugno Michael HDirector · Chairman, President and CEO
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 850,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001437749-20-013254 · rdgdoc.xml · derivative · entry 3 Tardugno Michael H · CIK 0001384550 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,346,071 Underlying: Celsion Corporation Common Stock · 850,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · derivative.underlying_shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:09 UTC |
Tardugno Michael HDirector · Chairman, President and CEO
|
Disposition to issuerOption to Purchase Celsion Corporation Common Stock · Derivative | 850,000 | $0.00 Strike: $2.22 | $0.00 |
DisclosureSEC source: 0001437749-20-013254 · rdgdoc.xml · derivative · entry 2 Tardugno Michael H · CIK 0001384550 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 510,071 Underlying: Celsion Corporation Common Stock · 850,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · derivative.underlying_shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:09 UTC |
Tardugno Michael HDirector · Chairman, President and CEO
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 135,000 | $0.00 Strike: $3.66 | $0.00 |
DisclosureSEC source: 0001437749-20-013254 · rdgdoc.xml · derivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,346,071 Underlying: Celsion Corporation Common Stock · 135,000 shares Expires 2030-06-15 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:07 UTC |
Voss AndreasDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 50,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001437749-20-013253 · rdgdoc.xml · derivative · entry 3 Voss Andreas · CIK 0001661447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,357 Underlying: Celsion Corporation Common Stock · 50,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · derivative.underlying_shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:07 UTC |
Voss AndreasDirector
|
Disposition to issuerOption to Purchase Celsion Corporation Common Stock · Derivative | 50,000 | $0.00 Strike: $2.22 | $0.00 |
DisclosureSEC source: 0001437749-20-013253 · rdgdoc.xml · derivative · entry 2 Voss Andreas · CIK 0001661447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,357 Underlying: Celsion Corporation Common Stock · 50,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · derivative.underlying_shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:07 UTC |
Voss AndreasDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 4,000 | $0.00 Strike: $3.66 | $0.00 |
DisclosureSEC source: 0001437749-20-013253 · rdgdoc.xml · derivative · entry 1 Voss Andreas · CIK 0001661447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,357 Underlying: Celsion Corporation Common Stock · 4,000 shares Expires 2030-06-15 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:06 UTC |
Martinez Alberto R JrDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 70,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001437749-20-013252 · rdgdoc.xml · derivative · entry 3 Martinez Alberto R Jr · CIK 0001507341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,880 Underlying: Celsion Corporation Common Stock · 70,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · derivative.underlying_shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:06 UTC |
Martinez Alberto R JrDirector
|
Disposition to issuerOption to Purchase Celsion Corporation Common Stock · Derivative | 70,000 | $0.00 Strike: $2.22 | $0.00 |
DisclosureSEC source: 0001437749-20-013252 · rdgdoc.xml · derivative · entry 2 Martinez Alberto R Jr · CIK 0001507341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,880 Underlying: Celsion Corporation Common Stock · 70,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · derivative.underlying_shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:06 UTC |
Martinez Alberto R JrDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 4,000 | $0.00 Strike: $3.66 | $0.00 |
DisclosureSEC source: 0001437749-20-013252 · rdgdoc.xml · derivative · entry 1 Martinez Alberto R Jr · CIK 0001507341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,880 Underlying: Celsion Corporation Common Stock · 4,000 shares Expires 2030-06-15 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:04 UTC |
Hooper Robert WDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 70,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001437749-20-013250 · rdgdoc.xml · derivative · entry 3 Hooper Robert W · CIK 0001497872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,737 Underlying: Celsion Corporation Common Stock · 70,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · derivative.underlying_shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:04 UTC |
Hooper Robert WDirector
|
Disposition to issuerOption to Purchase Celsion Corporation Common Stock · Derivative | 70,000 | $0.00 Strike: $2.22 | $0.00 |
DisclosureSEC source: 0001437749-20-013250 · rdgdoc.xml · derivative · entry 2 Hooper Robert W · CIK 0001497872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,737 Underlying: Celsion Corporation Common Stock · 70,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · derivative.underlying_shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:04 UTC |
Hooper Robert WDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 4,000 | $0.00 Strike: $3.66 | $0.00 |
DisclosureSEC source: 0001437749-20-013250 · rdgdoc.xml · derivative · entry 1 Hooper Robert W · CIK 0001497872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,737 Underlying: Celsion Corporation Common Stock · 4,000 shares Expires 2030-06-15 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:04 UTC |
Fritz Frederick J.Director
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 70,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001437749-20-013249 · rdgdoc.xml · derivative · entry 3 Fritz Frederick J. · CIK 0001525250 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,118 Underlying: Celsion Corporation Common Stock · 70,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · derivative.underlying_shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:04 UTC |
Fritz Frederick J.Director
|
Disposition to issuerOption to Purchase Celsion Corporation Common Stock · Derivative | 70,000 | $0.00 Strike: $2.22 | $0.00 |
DisclosureSEC source: 0001437749-20-013249 · rdgdoc.xml · derivative · entry 2 Fritz Frederick J. · CIK 0001525250 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,118 Underlying: Celsion Corporation Common Stock · 70,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · derivative.underlying_shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:04 UTC |
Fritz Frederick J.Director
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 4,000 | $0.00 Strike: $3.66 | $0.00 |
DisclosureSEC source: 0001437749-20-013249 · rdgdoc.xml · derivative · entry 1 Fritz Frederick J. · CIK 0001525250 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,118 Underlying: Celsion Corporation Common Stock · 4,000 shares Expires 2030-06-15 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:01 UTC |
Chow Pok Yu AugustineDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 70,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001437749-20-013245 · rdgdoc.xml · derivative · entry 3 Chow Pok Yu Augustine · CIK 0001392992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,689 Underlying: Celsion Corporation Common Stock · 70,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:01 UTC |
Chow Pok Yu AugustineDirector
|
Disposition to issuerOption to Purchase Celsion Corporation Common Stock · Derivative | 70,000 | $0.00 Strike: $2.22 | $0.00 |
DisclosureSEC source: 0001437749-20-013245 · rdgdoc.xml · derivative · entry 2 Chow Pok Yu Augustine · CIK 0001392992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,689 Underlying: Celsion Corporation Common Stock · 70,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:01 UTC |
Chow Pok Yu AugustineDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 4,000 | $0.00 Strike: $3.66 | $0.00 |
DisclosureSEC source: 0001437749-20-013245 · rdgdoc.xml · derivative · entry 1 Chow Pok Yu Augustine · CIK 0001392992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,689 Underlying: Celsion Corporation Common Stock · 4,000 shares Expires 2030-06-15 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:00 UTC |
Braun Donald PDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 50,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001437749-20-013243 · rdgdoc.xml · derivative · entry 3 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,357 Underlying: Celsion Corporation Common Stock · 50,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:00 UTC |
Braun Donald PDirector
|
Disposition to issuerOption to Purchase Celsion Corporation Common Stock · Derivative | 50,000 | $0.00 Strike: $2.22 | $0.00 |
DisclosureSEC source: 0001437749-20-013243 · rdgdoc.xml · derivative · entry 2 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,357 Underlying: Celsion Corporation Common Stock · 50,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · derivative.underlying_shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:00 UTC |
Braun Donald PDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 4,000 | $0.00 Strike: $3.66 | $0.00 |
DisclosureSEC source: 0001437749-20-013243 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,357 Underlying: Celsion Corporation Common Stock · 4,000 shares Expires 2030-06-15 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| February 28, 2020 Filed Feb 28, 2020 15:50 UTC |
Martinez Alberto R JrDirector
|
PurchaseCelsion Corporation Common Stock | 5,000 | $0.90 | $4,500.00 |
DisclosureSEC source: 0001437749-20-003851 · rdgdoc.xml · nonDerivative · entry 1 Martinez Alberto R Jr · CIK 0001507341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 F1 · shares: The shares were purchased on the open market. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:36 UTC |
Chow Pok Yu AugustineDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 6,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001437749-20-003771 · rdgdoc.xml · derivative · entry 1 Chow Pok Yu Augustine · CIK 0001392992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,689 Underlying: Celsion Corporation Common Stock · 6,000 shares Expires 2030-02-25 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 22:05 UTC |
Tumminello Timothy JController
|
GrantCelsion Corporation Common Stock | 14,500 | $1.16 | $16,820.00 |
DisclosureSEC source: 0001437749-20-003789 · rdgdoc.xml · nonDerivative · entry 1 Tumminello Timothy J · CIK 0001480334 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,258 F1 · shares: The Filer received Celsion Common Stock as part of their incentive compensation. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 22:02 UTC | GrantCelsion Corporation Common Stock | 47,000 | $1.16 | $54,520.00 |
DisclosureSEC source: 0001437749-20-003787 · rdgdoc.xml · nonDerivative · entry 1 CHURCH JEFFREY WAYNE · CIK 0001240203 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,298 F1 · shares: The Filer received Celsion Common Stock as part of their incentive compensation. Read SEC document |
|
| February 25, 2020 Filed Feb 27, 2020 22:01 UTC |
Tardugno Michael HDirector · Chairman, President and CEO
|
GrantCelsion Corporation Common Stock | 155,000 | $1.16 | $179,800.00 |
DisclosureSEC source: 0001437749-20-003785 · rdgdoc.xml · nonDerivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,700 F1 · shares: The Filer received Celsion Common Stock as part of their incentive compensation. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 22:00 UTC |
Braun Donald PDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 6,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001437749-20-003783 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,357 Underlying: Celsion Corporation Common Stock · 6,000 shares Expires 2030-02-25 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.